ADVERTISEMENT
  • The Membership Club
  • PT Hausa
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
Sunday, February 28, 2021
Premium Times Nigeria
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
Premium Times Nigeria
BUA Group Ad BUA Group Ad BUA Group Ad
ADVERTISEMENT
Covid-19 Laboratory test [PHOTO CREDIT: The Scientist Magazine]

Covid-19 Laboratory test [PHOTO CREDIT: The Scientist Magazine]

COVID-19: Africa CDC advises against use of Ivermectin

"Member States are advised against the use of Ivermectin for the prevention and treatment of COVID-19."

byChiamaka Okafor
February 20, 2021
2 min read
ADVERTISEMENT

The Africa Centres for Disease Control and Prevention (Africa CDC) has advised African countries against the use of Ivermectin for treating COVID-19.

“Member States are advised against the use of Ivermectin for the prevention and treatment of COVID-19 because there is no conclusive clinical data to support its safety and efficacy. The public is advised to adhere to country-specific guidelines for the prevention and treatment of COVID-19,” it said in a statement on Wednesday.

According to the Africa CDC, there is no scientific evidence from pre-clinical studies on the therapeutic effect of Ivermectin for the management of COVID-19; no evidence of its clinical efficacy for the management of patients with asymptomatic, mild, moderate or severe COVID-19; and no safety data regarding the use of Ivermectin for COVID-19 in the majority of the published studies.

However, it stated that “while there are some studies that suggest potential effectiveness of Ivermectin in the prevention and management of COVID-19, existing data has limitations.”

“These limitations include: most of the studies had small numbers of participants; the doses and schedules of Ivermectin administration varied; some patients taking Ivermectin were also on other medications during study; many of the studies did not clearly describe the severity of COVID-19; some of the randomized controlled trials were open-label studies.

“Although Ivermectin inhibits the replication of SARS-CoV-2 in laboratory studies, the doses used in the laboratory to produce those results are 100-fold higher than those approved for use in humans,” adding that data from well-designed, randomized, controlled clinical trials are needed to provide evidence for decision on the efficacy of Ivermectin for preventing and treating COVID-19.”

The centre said it will continue to monitor emerging evidence on the safety and efficacy of Ivermectin for the prevention and treatment of COVID-19 and provide update.

Ivermectin was very famous in the treatment of river blindness and used in treating parasitic infections such as scabies. Some scientists have said it also has antiviral components which stops the SARS-COV2 from duplicating itself in the human body.

ALSO READ: COVID-19: Forget Pfizer vaccine, administer Ivermectin on Nigerians, Neuroscientist tells Nigerian govt

There has been an exponential increase in the consumption of this drug which in turn led to an increase in the price of the drug as well as subtle scarcity.

RelatedNews

War Crimes: Final witness backs plaintiffs’ allegations Kosiah murdered civilians

Alleged War Crimes: Another Kosiah defence witness testifies against him

Boko Haram: Yobe government shuts all boarding schools

Chelsea vs Man United (LIVE UPDATES): Tuchel’s Blues face Red Devils

Also, a team at the Lagos University Teaching Hospital (LUTH) carried out a study on the use of Ivermectin in COVID-19 treatment. Findings of the study were recently shared with Vice President Yemi Osinbajo.

The study proposed that “Ivermectin should be considered for adoption into the uniform treatment guidelines of COVID-19 in Nigeria,” noting the “potential use of Ivermectin as prophylaxis pending the rollout of vaccination programmes or alongside it.”

However, the study emphasised that Ivermectin “is not meant to replace other COVID-19 measures such as social distancing, face masking and hygiene, or vaccinations,” adding that, “It is possibly an additional tool which can be deployed to fight the pandemic,” PREMIUM TIMES reported.

Dangote adbanner 728x90_2 (1)

Over 3.8 million COVID-19 cases have been confirmed on the African continent with more than 3.3 million recoveries & 100,000 deaths recorded.

  • WhatsApp
  • Tweet
  • Email
  • Print
  • Telegram
  • More
  • Share on Tumblr
  • Pocket

Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


TEXT AD: To advertise here . Call Willie +2347088095401...


JOIN THE CONVERSATION

  • Disqus (0)
premiumtimes



PT Mag Campaign AD

Previous Post

17-year-old Nigerian girl caught with gun in secondary school

Next Post

COVID-19: How five hardest hit African countries are coping

Chiamaka Okafor

Chiamaka Okafor

More News

Chelsea and Manchester United [PHOTO CREDIT: @ChelseaFC]

EPL Round-Up: Chelsea, Man United tie ends in stalemate

February 28, 2021
Rats used to illustrate the story. [PHOTO CREDIT: BBC]

Major health stories published last week

February 28, 2021
Dangote refinery

Dangote Refinery to sell refined crude in naira – Emefiele

February 28, 2021
APC: Mai Mala Buni, Yobe State Governor [PHOTO: Media Office, Yobe State Government House, Damaturu]

Boko Haram: Yobe government shuts all boarding schools

February 28, 2021
Salihu Tanko-Yakassai

Why DSS arrested Tanko-Yakassai -Official

February 28, 2021
Muslims criticise WAEC over exams timetable

Hijab Controversy: Christian leaders reject Kwara govt. decision as students resume on Monday

February 28, 2021
Next Post
Map of AFrica

COVID-19: How five hardest hit African countries are coping

Chinonye Ezem

Women in Agriculture: How missing Pharmacy admission helped me - Farmer

Discussion about this post

Search

#EndSARS: Latest Updates




Polaris Bank


JAIZ Ad


NITDA Ad





Glo Ad

Subscribe to News via Email

Enter your email address and receive notifications of news by email.

Join 1,626,466 other subscribers.

Advertisement






netherland biz school Advert

Zenith Advert
ADVERTISEMENT

Our Digital Network

  • PT Hausa
  • Election Centre
  • Human Trafficking Investigation
  • Centre for Investigative Journalism
  • National Conference
  • Press Attack Tracker
  • PT Academy
  • Dubawa
  • LeaksNG
  • Campus Reporter

Resources

  • Oil & Gas Facts
  • List of Universities in Nigeria
  • LIST: Federal Unity Colleges in Nigeria
  • NYSC Orientation Camps in Nigeria
  • Nigeria’s Federal/States’ Budgets since 2005
  • Malabu Scandal Thread
  • World Cup 2018
  • Panama Papers Game
  • Our Digital Network
  • About Us
  • Resources
  • Projects
  • Data & Infographics
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

No Result
View All Result
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Panama Papers
    • Paradise Papers
    • Parliament Watch
    • AGAHRIN
  • Opinion
  • PT Hausa
  • The Membership Club
  • Dubawa
    • Dubawa NG
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
  • Digital Store
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

Our website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.